Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model

Abstract excerpt

BACKGROUND: Dolutegravir (DTG) is a recommended first-line regimen for all people with Human Immunodeficiency Virus (HIV) infection. Initial findings from Botswana, a country with no folate fortification program, showed an elevated prevalence of neural tube defects (NTDs) with peri-conceptional exposure to DTG. Here we explore whether a low folate diet influences the risk of DTG-associated foetal anomalies in a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Folate and B Vitamins Research
• Share to HIV/AIDS drug development and treatment
• Share to Pharmacological Effects and Toxicity Studies